Document is current
Any future updates will be listed below
-
Authors
Yao, Jingwen
Tan, Caleb Hock Pang
Schlossman, Jacob
Chakhoyan, Ararat
Raymond, Catalina
Pope, Whitney B.
Salamon, Noriko
Lai, Albert
Ji, Matthew
Nghiemphu, Phioanh L.
Liau, Linda M.
Cloughesy, Timothy F.
Ellingson, Benjamin M. https://orcid.org/0000-0002-2764-6640
-
Funding
Funding for this research was provided by:
American Cancer Society (RSG-15-003-01-CCE)
National Cancer Institute (1P50CA211015-01A1, 1R21CA223757-01)
Jonsson Comprehensive Cancer Center
- License Information
-
More Information
Article History
Received: 10 January 2019
Accepted: 21 February 2019
First Online: 26 February 2019
Compliance with ethical standards
:
: Ellingson—Advisory Board—<i>Hoffman La-Roche; Siemens; Nativis; Medicenna; MedQIA; Bristol Meyers Squibb; Imaging Endpoints; Agios</i>. Paid Consultant—<i>Nativis; MedQIA; Siemens; Hoffman La-Roche; Imaging Endpoints; Medicenna; Agios</i>. Grant Funding—<i>Hoffman La-Roche; Siemens; Agios; Janssen</i>. Dr. Ellingson also holds a patent on this technology (US Patent #15/577,664; International PCT/US2016/034886). Cloughesy—Advisory Board—<i>Roche</i>/<i>Genentech, Amgen, Tocagen, NewGen, LPath, Proximagen, Celgene, Vascular Biogenics Ltd, Insys, Agios, Cortice Bioscience, Pfizer, Human Longevity, BMS, Merck, Notable Lab, MedQIA</i>.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
